Wenfang He

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Anti Inflammatory

Long Noncoding Rna

Top Venues

Cancer research

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Juan Ji, Fen Chen, Wenfang He, Li Zhao, Bo Lin, Danna Zheng, Li Chen, Hongchao He, Qiang He
YAP-activated SATB2 is a coactivator of NRF2 that amplifies anti-oxidative capacity and promotes tumor progression in renal cell carcinoma. Cancer research (2023)
Juan Ji, Fen Chen, Wenfang He, Li Zhao, Bo Lin, Danna Zheng, Li Chen, Hongchao He, Qiang He
YAP-Activated SATB2 Is a Coactivator of NRF2 That Amplifies Antioxidative Capacity and Promotes Tumor Progression in Renal Cell Carcinoma. Cancer research 83 (5) (2023)
Juan Ji, Fen Chen, Wenfang He, Li Zhao, Bo Lin, Danna Zheng, Li Chen, Hongchao He, Qiang He
YAP-Activated SATB2 Is a Coactivator of NRF2 That Amplifies Antioxidative Capacity and Promotes Tumor Progression in Renal Cell Carcinoma. Cancer research 83 (5) (2023)
Juan Ji, Fen Chen, Wenfang He, Li Zhao, Bo Lin, Danna Zheng, Li Chen, Hongchao He, Qiang He
YAP-Activated SATB2 Is a Coactivator of NRF2 That Amplifies Antioxidative Capacity and Promotes Tumor Progression in Renal Cell Carcinoma. Cancer research 83 (5) (2023)
Mengjie Yu, Xiaogang Shen, Wenfang He, Danna Zheng, Qiang He, Juan Jin
Mesangial Cell-Derived Exosomal miR-4455 Induces Podocyte Injury in IgA Nephropathy by Targeting ULK2. Oxidative medicine and cellular longevity 2022 (2022)